The invention relates to the use of a compound which acts as an antagonist of 5-HT at 5-HT3 receptors in the treatment of autism or another disorder originating in childhood in which there is mental retardation.
USE OF 5-HYDROXYTRYPTAMINE-ANTAGONISTS IN THE TREATMENT OF MENTAL DISORDERS ORIGINATING IN CHILDHOOD